DM
TYRA icon

Deerfield Management’s Tyra Biosciences TYRA Stock Holding History

Deerfield Management’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21M Buy
+549,000
New +$17.8M 0.25% 60
2021
Q4 		– Sell
-625,000
Closed -$11M – 142
2021
Q3 		$11M Buy
+625,000
New +$11.9M 0.21% 88

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $151M AUM 296.21% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Deerfield Management's TYRA Position: Q1 2026 in Review

Deerfield Management opened a new position in Tyra Biosciences (TYRA) in Q1 2026: 549,000 shares worth $21M. The stake represents 0.25% of the portfolio and ranks #60 among its holdings. This is a return to the name: Deerfield Management previously reported a position in TYRA as recently as Q3 2021.

Deerfield Management first reported a position in TYRA in Q3 2021 and has held it in 2 quarters since. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • Deerfield Management held 549,000 shares of Tyra Biosciences worth $21M as of Q1 2026.
  • Tyra Biosciences was a new Deerfield Management position in Q1 2026.
  • Tyra Biosciences made up 0.25% of Deerfield Management's portfolio in Q1 2026, its #60 holding.
  • Deerfield Management first reported a position in Tyra Biosciences in Q3 2021 and has held it in 2 quarters since.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on Deerfield Management's 13F filing for Q1 2026, filed 15 May 2026.